Recent Articles

All product descriptions and articles provided on this website are intended strictly for informational and educational purposes. Our products are designed exclusively for in-vitro research (i.e., experiments conducted outside of a living organism, typically in glassware such as test tubes or petri dishes). These compounds are not approved by the FDA for use in humans or animals. They are not medications, nor are they intended to diagnose, treat, prevent, or cure any disease or medical condition. Any bodily administration-human or animal-is strictly prohibited by law. Our products are not for human consumption under any circumstances.

Diagram image showing AOD-9604 reducing obesity, stress, and improving neural metabolism and cognition.

Does Current Research Associate AOD-9604 With N...

This research-focused article examines how AOD-9604 may impact metabolic brain pathways associated with obesity-related cognitive decline. It highlights emerging preclinical and clinical evidence, including support for neural metabolism, reduced neuroinflammation, and potential neuroprotective effects. Researchers studying adipose-brain signaling, metabolic peptides, and cognitive outcomes will find detailed insights, mechanisms, and CTA guidance for accessing high-purity AOD-9604 strictly for laboratory use.

 

Posted in: News

read more
Diagram showing how NAD⁺ boosting peptides reduce oxidative stress and support neuronal survival.

What Evidence Supports NAD+ Boosting Peptides i...

This blog explores how NAD⁺-boosting peptides protect neurons during ischemic stroke by preserving energy, supporting mitochondria, and reducing oxidative stress. It highlights key mechanisms involving sirtuins, PARP regulation, and NAD⁺ salvage pathways, along with preclinical evidence validating these strategies in stroke models. Learn why high-purity research peptides are essential for advancing ischemia neuroprotection studies.

 

Posted in: News

read more